Revise monthly events by exam family instead of reading random updates.

GK and monthly revision
Biosimilars and innovation will drive Indian pharma's next growth phase: Vishal Manchanda
India's pharmaceutical sector is transitioning from generics to biosimilars, nutraceuticals, and consumer healthcare, indicating a significant shift in strategy. This evolution is crucial as companies face challenges with US FDA approvals for complex generics, yet see potential in innovation and contract manufacturing. The anticipated revenue generation from biosimilars, alongside the promise of GLP-1 drugs, underscores the sector's growth potential, with Sun Pharma being a notable investment choice.
Revision structure
How to study
Turn news into exam marks
Pair one-liners with mock tests so mistakes become the next revision list.
Keep state job pages, calendar pages and GK packs connected in one path.